RA
Rosalind Advisors Portfolio holdings
AUM
$274M
1-Year Est. Return
82.13%
This Fund
S&P 500
1 Year Est. Return
+82.13%
AUM
$274M
AUM Growth
-$8.51M
(-3%)
Holding
42
Top Buys
| 1 | +$12M | |
| 2 | +$4.49M | |
| 3 | +$4.41M | |
| 4 |
X4 Pharmaceuticals
XFOR
|
+$3.86M |
| 5 |
Xeris Biopharma Holdings
XERS
|
+$2.49M |
Top Sells
| 1 | +$14.2M | |
| 2 | +$12.7M | |
| 3 | +$10.7M | |
| 4 |
IDEAYA Biosciences
IDYA
|
+$9.52M |
| 5 |
Fractyl Health
GUTS
|
+$7.43M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Delcath Systems
DCTH
$309M
| $33M | 12.02% |
3,300,389
|
|
||
2
Savara
SVRA
$1.22B
| $20.5M | 7.48% |
3,403,721
-596,279
|
|
||
3
Fennec Pharmaceuticals
FENC
$290M
| $20.1M | 7.33% |
2,613,508
+536,668
|
|
||
|
4
Xeris Biopharma Holdings
XERS
$1.02B
| $16.6M | 6.04% |
2,111,700
+315,934
|
|
||
5
Viridian Therapeutics
VRDN
$2.8B
| $14M | 5.1% |
450,000
-150,000
|
|
||
6
MediWound
MDWD
$222M
| $13.8M | 5.04% |
749,054
|
|
||
7
Verastem
VSTM
$431M
| $13.8M | 5.03% |
1,788,475
-141,088
|
|
||
8
Replimune Group
REPL
$632M
| $13.7M | 5% |
+1,410,497
|
|
||
|
ATYR
9
aTyr Pharma
ATYR
$94M
| $13.6M | 4.96% |
1,039,080
|
|
||
|
HELP
10
Cybin Inc
HELP
$367M
| $13.6M | 4.94% |
1,657,540
+157,540
|
|
||
11
EyePoint Inc
EYPT
$1.45B
| $12.6M | 4.59% |
690,000
+40,000
|
|
||
12
CG Oncology
CGON
$4.86B
| $12.5M | 4.54% |
300,000
|
|
||
13
Cytokinetics
CYTK
$7.61B
| $12.4M | 4.52% |
195,045
-204,955
|
|
||
|
14
X4 Pharmaceuticals
XFOR
$301M
| $10.4M | 3.8% |
2,605,920
+1,061,313
|
|
||
|
DFTX
15
Definium Therapeutics
DFTX
$1.72B
| $10M | 3.66% |
750,000
|
|
||
|
PROF
16
Profound Medical
PROF
$276M
| $8.41M | 3.07% |
1,068,955
+376,770
|
|
||
17
InspireMD
NSPR
$75.4M
| $6.95M | 2.53% |
3,905,743
|
|
||
18
Ocular Therapeutix
OCUL
$1.95B
| $4.86M | 1.77% |
400,000
|
|
||
19
ArriVent BioPharma
AVBP
$948M
| $4.34M | 1.58% |
+215,871
|
|
||
20
Talphera
TLPH
$42.5M
| $4.08M | 1.49% |
3,579,273
-806,484
|
|
||
21
Myomo
MYO
$29.8M
| $3.49M | 1.27% |
3,839,772
+48,984
|
|
||
22
PolyPid
PYPD
$77.4M
| $3.02M | 1.1% |
696,556
-222,112
|
|
||
|
OKUR
23
OnKure Therapeutics
OKUR
$36.7M
| $2.12M | 0.77% |
+730,488
|
|
||
|
RGNT
24
Regentis Biomaterials
RGNT
$20.5M
| $1.7M | 0.62% |
+251,510
|
|
||
25
Trevi Therapeutics
TRVI
$1.53B
| $1.25M | 0.46% |
100,000
|
|